Head And Neck Cancer - Pipeline Review, H2 2016


#862959

1153pages

Global Markets Direct

$ 2500

In Stock

Head And Neck Cancer - Pipeline Review, H2 2016

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 17, 73, 86, 6, 76, 18 and 2 respectively for Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 9, 6, 16 and 3 molecules, respectively for Head And Neck Cancer.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
Introduction 9
Head And Neck Cancer Overview 10
Therapeutics Development 11
Head And Neck Cancer - Therapeutics under Development by Companies 13
Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes 27
Head And Neck Cancer - Pipeline Products Glance 29
Head And Neck Cancer - Products under Development by Companies 33
Head And Neck Cancer - Products under Investigation by Universities/Institutes 54
Head And Neck Cancer - Companies Involved in Therapeutics Development 57
Head And Neck Cancer - Therapeutics Assessment 225
Drug Profiles 260
Head And Neck Cancer - Dormant Projects 1081
Head And Neck Cancer - Discontinued Products 1097
Head And Neck Cancer - Product Development Milestones 1100
Appendix 1119

List of Tables
Number of Products under Development for Head And Neck Cancer, H2 2016 44
Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016 45
Number of Products under Development by Companies, H2 2016 46
Number of Products under Development by Companies, H2 2016 (Contd..1) 47
Number of Products under Development by Companies, H2 2016 (Contd..2) 48
Number of Products under Development by Companies, H2 2016 (Contd..3) 49
Number of Products under Development by Companies, H2 2016 (Contd..4) 50
Number of Products under Development by Companies, H2 2016 (Contd..5) 51
Number of Products under Development by Companies, H2 2016 (Contd..6) 52
Number of Products under Development by Companies, H2 2016 (Contd..7) 53
Number of Products under Development by Companies, H2 2016 (Contd..8) 54
Number of Products under Development by Companies, H2 2016 (Contd..9) 55
Number of Products under Development by Companies, H2 2016 (Contd..10) 56
Number of Products under Development by Companies, H2 2016 (Contd..11) 57
Number of Products under Development by Companies, H2 2016 (Contd..12) 58
Number of Products under Development by Companies, H2 2016 (Contd..13) 59
Number of Products under Investigation by Universities/Institutes, H2 2016 60
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 61
Comparative Analysis by Late Stage Development, H2 2016 62
Comparative Analysis by Clinical Stage Development, H2 2016 63
Comparative Analysis by Early Stage Development, H2 2016 64
Comparative Analysis by Unknown Stage Development, H2 2016 65
Products under Development by Companies, H2 2016 66
Products under Development by Companies, H2 2016 (Contd..1) 67
Products under Development by Companies, H2 2016 (Contd..2) 68
Products under Development by Companies, H2 2016 (Contd..3) 69
Products under Development by Companies, H2 2016 (Contd..4) 70
Products under Development by Companies, H2 2016 (Contd..5) 71
Products under Development by Companies, H2 2016 (Contd..6) 72
Products under Development by Companies, H2 2016 (Contd..7) 73
Products under Development by Companies, H2 2016 (Contd..8) 74
Products under Development by Companies, H2 2016 (Contd..9) 75
Products under Development by Companies, H2 2016 (Contd..10) 76
Products under Development by Companies, H2 2016 (Contd..11) 77
Products under Development by Companies, H2 2016 (Contd..12) 78
Products under Development by Companies, H2 2016 (Contd..13) 79
Products under Development by Companies, H2 2016 (Contd..14) 80
Products under Development by Companies, H2 2016 (Contd..15) 81
Products under Development by Companies, H2 2016 (Contd..16) 82
Products under Development by Companies, H2 2016 (Contd..17) 83
Products under Development by Companies, H2 2016 (Contd..18) 84
Products under Development by Companies, H2 2016 (Contd..19) 85
Products under Development by Companies, H2 2016 (Contd..20) 86
Products under Investigation by Universities/Institutes, H2 2016 87
Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 88
Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 89
Head And Neck Cancer - Pipeline by 3SBio Inc., H2 2016 90
Head And Neck Cancer - Pipeline by 4SC AG, H2 2016 91
Head And Neck Cancer - Pipeline by AB Science SA, H2 2016 92
Head And Neck Cancer - Pipeline by AbbVie Inc, H2 2016 93
Head And Neck Cancer - Pipeline by Accelerated Pharma, Inc., H2 2016 94
Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H2 2016 95
Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2016 96
Head And Neck Cancer - Pipeline by Aduro BioTech, Inc., H2 2016 97
Head And Neck Cancer - Pipeline by Advaxis, Inc., H2 2016 98
Head And Neck Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2016 99
Head And Neck Cancer - Pipeline by Affimed GmbH , H2 2016 100
Head And Neck Cancer - Pipeline by Alchemia Limited, H2 2016 101
Head And Neck Cancer - Pipeline by Altor BioScience Corporation, H2 2016 102
Head And Neck Cancer - Pipeline by Ambrx, Inc., H2 2016 103
Head And Neck Cancer - Pipeline by Amgen Inc., H2 2016 104
Head And Neck Cancer - Pipeline by arGEN-X BV, H2 2016 105
Head And Neck Cancer - Pipeline by ArQule, Inc., H2 2016 106
Head And Neck Cancer - Pipeline by Aspyrian Therapeutics, Inc., H2 2016 107
Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H2 2016 108
Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2016 109
Head And Neck Cancer - Pipeline by Atara Biotherapeutics, Inc., H2 2016 110
Head And Neck Cancer - Pipeline by ATLAB Pharma SAS, H2 2016 111
Head And Neck Cancer - Pipeline by Aura Biosciences, Inc., H2 2016 112
Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2016 113
Head And Neck Cancer - Pipeline by Bayer AG, H2 2016 114
Head And Neck Cancer - Pipeline by Betta Pharmaceuticals Co. Ltd., H2 2016 115
Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC, H2 2016 116
Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H2 2016 117
Head And Neck Cancer - Pipeline by BioDiem Ltd, H2 2016 118
Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co., Ltd., H2 2016 119
Head And Neck Cancer - Pipeline by Bionovis SA, H2 2016 120
Head And Neck Cancer - Pipeline by BioNTech AG, H2 2016 121
Head And Neck Cancer - Pipeline by Biotest AG, H2 2016 122
Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016 123
Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H2 2016 124
Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016 125
Head And Neck Cancer - Pipeline by Calithera Biosciences, Inc., H2 2016 126
Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H2 2016 127
Head And Neck Cancer - Pipeline by Celgene Corporation, H2 2016 128
Head And Neck Cancer - Pipeline by Cell Medica Limited, H2 2016 129
Head And Neck Cancer - Pipeline by Cellceutix Corporation, H2 2016 130
Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2016 131
Head And Neck Cancer - Pipeline by Celprogen, Inc., H2 2016 132
Head And Neck Cancer - Pipeline by Centrose LLC, H2 2016 133
Head And Neck Cancer - Pipeline by Corvus Pharmaceuticals, Inc., H2 2016 134
Head And Neck Cancer - Pipeline by Cristal Therapeutics B.V., H2 2016 135
Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2016 136
Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H2 2016 137
Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2016 138
Head And Neck Cancer - Pipeline by DNJ Pharma, Inc., H2 2016 139
Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H2 2016 140
Head And Neck Cancer - Pipeline by Eleven Biotherapeutics Inc., H2 2016 141
Head And Neck Cancer - Pipeline by Eli Lilly and Company, H2 2016 142
Head And Neck Cancer - Pipeline by EntreChem, S.L., H2 2016 143
Head And Neck Cancer - Pipeline by Etubics Corporation, H2 2016 144
Head And Neck Cancer - Pipeline by Eureka Therapeutics, Inc., H2 2016 145
Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 146
Head And Neck Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2016 147
Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2016 148
Head And Neck Cancer - Pipeline by Genelux Corporation, H2 2016 149
Head And Neck Cancer - Pipeline by GeneSegues Inc, H2 2016 150
Head And Neck Cancer - Pipeline by Genexine, Inc., H2 2016 151
Head And Neck Cancer - Pipeline by Genmab A/S, H2 2016 152
Head And Neck Cancer - Pipeline by Genticel S.A., H2 2016 153
Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016 154
Head And Neck Cancer - Pipeline by Gliknik, Inc., H2 2016 155
Head And Neck Cancer - Pipeline by Glycotope GmbH, H2 2016 156
Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016 157
Head And Neck Cancer - Pipeline by Hookipa Biotech AG, H2 2016 158
Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2 2016 159
Head And Neck Cancer - Pipeline by Hutchison MediPharma Limited, H2 2016 160
Head And Neck Cancer - Pipeline by Ignyta, Inc., H2 2016 161
Head And Neck Cancer - Pipeline by Immunomedics, Inc., H2 2016 162
Head And Neck Cancer - Pipeline by Immunovaccine, Inc., H2 2016 163
Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2016 164
Head And Neck Cancer - Pipeline by Incuron, LLC, H2 2016 165
Head And Neck Cancer - Pipeline by Incyte Corporation, H2 2016 166
Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 167
Head And Neck Cancer - Pipeline by Innate Pharma S.A., H2 2016 168
Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2016 169
Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H2 2016 170
Head And Neck Cancer - Pipeline by IRX Therapeutics, Inc., H2 2016 171
Head And Neck Cancer - Pipeline by ISA Pharmaceuticals B.V., H2 2016 172
Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2016 173
Head And Neck Cancer - Pipeline by Johnson & Johnson, H2 2016 174
Head And Neck Cancer - Pipeline by Kite Pharma Inc, H2 2016 175
Head And Neck Cancer - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016 176
Head And Neck Cancer - Pipeline by Kura Oncology, Inc., H2 2016 177
Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2 2016 178
Head And Neck Cancer - Pipeline by Lakewood-Amedex Inc, H2 2016 179
Head And Neck Cancer - Pipeline by Loxo Oncology, Inc., H2 2016 180
Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2 2016 181
Head And Neck Cancer - Pipeline by Mabion SA, H2 2016 182
Head And Neck Cancer - Pipeline by Mabtech Limited, H2 2016 183
Head And Neck Cancer - Pipeline by MacroGenics, Inc., H2 2016 184
Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H2 2016 185
Head And Neck Cancer - Pipeline by Mateon Therapeutics Inc, H2 2016 186
Head And Neck Cancer - Pipeline by MaxiVAX SA, H2 2016 187
Head And Neck Cancer - Pipeline by Meabco A/S, H2 2016 188
Head And Neck Cancer - Pipeline by MedImmune, LLC, H2 2016 189
Head And Neck Cancer - Pipeline by Merck & Co., Inc., H2 2016 190
Head And Neck Cancer - Pipeline by Merck KGaA, H2 2016 191
Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2016 192
Head And Neck Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2 2016 193
Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H2 2016 194
Head And Neck Cancer - Pipeline by Molecular Partners AG, H2 2016 195
Head And Neck Cancer - Pipeline by Moleculin Biotech Inc, H2 2016 196
Head And Neck Cancer - Pipeline by Molplex Ltd., H2 2016 197
Head And Neck Cancer - Pipeline by NanoCarrier Co., Ltd., H2 2016 198
Head And Neck Cancer - Pipeline by Natco Pharma Limited, H2 2016 199
Head And Neck Cancer - Pipeline by Neonc Technologies Inc, H2 2016 200
Head And Neck Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2016 201
Head And Neck Cancer - Pipeline by Novartis AG, H2 2016 202
Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H2 2016 203
Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H2 2016 204
Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc, H2 2016 205
Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H2 2016 206
Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2016 207
Head And Neck Cancer - Pipeline by OncoSec Medical Incorporated, H2 2016 208
Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016 209
Head And Neck Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2016 210
Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H2 2016 211
Head And Neck Cancer - Pipeline by PCI Biotech Holding ASA, H2 2016 212
Head And Neck Cancer - Pipeline by PDS Biotechnology Corporation, H2 2016 213
Head And Neck Cancer - Pipeline by Pfizer Inc., H2 2016 214
Head And Neck Cancer - Pipeline by Pharma Mar, S.A., H2 2016 215
Head And Neck Cancer - Pipeline by Pique Therapeutics, H2 2016 216
Head And Neck Cancer - Pipeline by PlantForm Corporation, H2 2016 217
Head And Neck Cancer - Pipeline by Plexxikon Inc., H2 2016 218
Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H2 2016 219
Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H2 2016 220
Head And Neck Cancer - Pipeline by ProNAi Therapeutics, Inc., H2 2016 221
Head And Neck Cancer - Pipeline by Provectus Biopharmaceuticals, Inc., H2 2016 222
Head And Neck Cancer - Pipeline by R-Pharm, H2 2016 223
Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2 2016 224
Head And Neck Cancer - Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016 225
Head And Neck Cancer - Pipeline by Sanofi, H2 2016 226
Head And Neck Cancer - Pipeline by Sapvax, H2 2016 227
Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2 2016 228
Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H2 2016 229
Head And Neck Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2016 230
Head And Neck Cancer - Pipeline by Shenzen SiBiono GeneTech Co., Ltd., H2 2016 231
Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H2 2016 232
Head And Neck Cancer - Pipeline by Silence Therapeutics Plc, H2 2016 233
Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2 2016 234
Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2016 235
Head And Neck Cancer - Pipeline by SuviCa Inc., H2 2016 236
Head And Neck Cancer - Pipeline by Symphogen A/S, H2 2016 237
Head And Neck Cancer - Pipeline by SynCore Biotechnology Co., Ltd., H2 2016 238
Head And Neck Cancer - Pipeline by Taiwan Liposome Company, Ltd., H2 2016 239
Head And Neck Cancer - Pipeline by Takara Bio Inc., H2 2016 240
Head And Neck Cancer - Pipeline by Takis S.r.l., H2 2016 241
Head And Neck Cancer - Pipeline by Tara Immuno-Oncology Therapeutics LLC, H2 2016 242
Head And Neck Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2016 243
Head And Neck Cancer - Pipeline by Theravectys SA, H2 2016 244
Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals, Inc., H2 2016 245
Head And Neck Cancer - Pipeline by TyrNovo Ltd., H2 2016 246
Head And Neck Cancer - Pipeline by UbiVac, LLC, H2 2016 247
Head And Neck Cancer - Pipeline by Vaccibody AS, H2 2016 248
Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H2 2016 249
Head And Neck Cancer - Pipeline by Vault Pharma Inc., H2 2016 250
Head And Neck Cancer - Pipeline by Vaxeal Holding SA, H2 2016 251
Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2016 252
Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H2 2016 253
Head And Neck Cancer - Pipeline by VLPbio, H2 2016 254
Head And Neck Cancer - Pipeline by VM Discovery, Inc., H2 2016 255
Head And Neck Cancer - Pipeline by Vyriad Inc, H2 2016 256
Head And Neck Cancer - Pipeline by Yabao Pharmaceutical Group Co., Ltd., H2 2016 257
Assessment by Monotherapy Products, H2 2016 258
Assessment by Combination Products, H2 2016 259
Number of Products by Stage and Target, H2 2016 261
Number of Products by Stage and Mechanism of Action, H2 2016 275
Number of Products by Stage and Route of Administration, H2 2016 290
Number of Products by Stage and Molecule Type, H2 2016 292
Head And Neck Cancer - Dormant Projects, H2 2016 1114
Head And Neck Cancer - Dormant Projects (Contd..1), H2 2016 1115
Head And Neck Cancer - Dormant Projects (Contd..2), H2 2016 1116
Head And Neck Cancer - Dormant Projects (Contd..3), H2 2016 1117
Head And Neck Cancer - Dormant Projects (Contd..4), H2 2016 1118
Head And Neck Cancer - Dormant Projects (Contd..5), H2 2016 1119
Head And Neck Cancer - Dormant Projects (Contd..6), H2 2016 1120
Head And Neck Cancer - Dormant Projects (Contd..7), H2 2016 1121
Head And Neck Cancer - Dormant Projects (Contd..8), H2 2016 1122
Head And Neck Cancer - Dormant Projects (Contd..9), H2 2016 1123
Head And Neck Cancer - Dormant Projects (Contd..10), H2 2016 1124
Head And Neck Cancer - Dormant Projects (Contd..11), H2 2016 1125
Head And Neck Cancer - Dormant Projects (Contd..12), H2 2016 1126
Head And Neck Cancer - Dormant Projects (Contd..13), H2 2016 1127
Head And Neck Cancer - Dormant Projects (Contd..14), H2 2016 1128
Head And Neck Cancer - Dormant Projects (Contd..15), H2 2016 1129
Head And Neck Cancer - Discontinued Products, H2 2016 1130
Head And Neck Cancer - Discontinued Products (Contd..1), H2 2016 1131
Head And Neck Cancer - Discontinued Products (Contd..2), H2 2016 1132

List of Figures
Number of Products under Development for Head And Neck Cancer, H2 2016 44
Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016 45
Number of Products under Development by Companies, H2 2016 46
Number of Products under Investigation by Universities/Institutes, H2 2016 60
Comparative Analysis by Late Stage Development, H2 2016 62
Comparative Analysis by Clinical Stage Development, H2 2016 63
Comparative Analysis by Early Stage Products, H2 2016 64
Assessment by Monotherapy Products, H2 2016 258
Assessment by Combination Products, H2 2016 259
Number of Products by Top 10 Targets, H2 2016 260
Number of Products by Stage and Top 10 Targets, H2 2016 260
Number of Products by Top 10 Mechanism of Actions, H2 2016 274
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 274
Number of Products by Top 10 Routes of Administration, H2 2016 289
Number of Products by Stage and Top 10 Routes of Administration, H2 2016 289
Number of Products by Top 10 Molecule Types, H2 2016 291
Number of Products by Stage and Top 10 Molecule Types, H2 2016 291

NA

NA